Replies to post #77578 on Biotech Values

[microcapfun]

HGS, Novozymes, albumin fusion

>>It’s unclear to me why HGSI still has rights to the albumin-fusion technology that is the subject of this revised license with Novozymes. I thought Teva had acquired the rights to such technology when it bought HGSI’s CoGenesys subsidiary in early 2008<<

It seems HGS only gave CoGenesys a non-exclusive license to the albumin-fusion tech.

>>Human Genome Sciences will grant CoGenesys exclusive rights to develop and commercialize biological products based on certain human genes discovered by HGS, and will grant CoGenesys a license to use its proprietary albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use.<<
http://www.hgsi.com/latest/human-genome-sciences-announces-decision-to-spin-off-cogenesys-division-as-an-independent-co-2.html

micro